Literature DB >> 26101934

Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats.

Laura J Mosher1,2,3, Roberto Frau4, Alessandra Pardu4, Romina Pes1, Paola Devoto4, Marco Bortolato1,2,3.   

Abstract

BACKGROUND AND
PURPOSE: Sensorimotor gating is a perceptual process aimed at filtering out irrelevant information. In humans and animal models, this function can be operationally measured through the prepulse inhibition (PPI) of the acoustic startle reflex. Notably, PPI deficits are associated with numerous neuropsychiatric conditions characterized by gating disturbances, including schizophrenia and Tourette syndrome. Ample evidence has shown that dopamine plays a key role in PPI regulation and, in particular, rodent studies indicate that this neurotransmitter modulates PPI through D1 and D2 dopamine receptors. In mice, the relative contributions of these two families of receptors are strain-dependent. Conversely, the role of D1 receptors in the regulation of PPI across different rat strains remains unclear. EXPERIMENTAL APPROACH: We tested the effects of selective D1 and D2 receptor agonists and antagonists on the startle reflex and PPI of Sprague-Dawley, Wistar and Long-Evans rats. KEY
RESULTS: In contrast with Sprague-Dawley and Wistar rats, the full D1 receptor agonist SKF82958 elicited significant PPI deficits in Long-Evans rats, an effect sensitive to the selective D1 antagonist SCH23390. CONCLUSIONS AND IMPLICATIONS: Our results suggest that, in Long-Evans rats, D1 receptor activation may be sufficient to significantly impair PPI. These data emphasize the role of D1 receptors in the pathophysiology of neuropsychiatric disorders featuring alterations in sensorimotor gating, and uphold the importance of the genetic background in shaping the role of dopamine receptors in the regulation of this key information-processing function. LINKED ARTICLES: This article is part of a themed section on Updating Neuropathology and Neuropharmacology of Monoaminergic Systems. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v173.13/issuetoc.
© 2015 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26101934      PMCID: PMC4908197          DOI: 10.1111/bph.13232

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  66 in total

1.  Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens.

Authors:  N R Swerdlow; D L Braff; V L Masten; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 2.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

Review 3.  Cross-species studies of sensorimotor gating of the startle reflex.

Authors:  N R Swerdlow; D L Braff; M A Geyer
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

4.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.

Authors:  C R Gerfen; T M Engber; L C Mahan; Z Susel; T N Chase; F J Monsma; D R Sibley
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

5.  A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.

Authors:  R Y Peng; R S Mansbach; D L Braff; M A Geyer
Journal:  Neuropsychopharmacology       Date:  1990-06       Impact factor: 7.853

Review 6.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

7.  Startle habituation and sensorimotor gating in schizophrenia and related animal models.

Authors:  M A Geyer; D L Braff
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

8.  Heritable differences in the dopaminergic regulation of sensorimotor gating. I. Apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny.

Authors:  Neal R Swerdlow; Jody M Shoemaker; Amanda Platten; Leia Pitcher; Jana Goins; Pamela P Auerbach
Journal:  Psychopharmacology (Berl)       Date:  2003-05-21       Impact factor: 4.530

Review 9.  The genetics of Tourette syndrome: a review.

Authors:  Julia A O'Rourke; Jeremiah M Scharf; Dongmei Yu; David L Pauls
Journal:  J Psychosom Res       Date:  2009-09-30       Impact factor: 3.006

10.  Interactive effects of stimulation of D1 and D2 dopamine receptors on fos-like immunoreactivity in the normosensitive rat striatum.

Authors:  D Wirtshafter; K E Asin
Journal:  Brain Res Bull       Date:  1994       Impact factor: 4.077

View more
  12 in total

1.  Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation.

Authors:  Laura J Mosher; Roberto Cadeddu; Sabrina Yen; Jeffrey L Staudinger; Francesco Traccis; Stephen C Fowler; Jamie L Maguire; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2019-06-14       Impact factor: 4.905

2.  Baseline prepulse inhibition of the startle reflex predicts the sensitivity to the conditioned rewarding effects of cocaine in male and female mice.

Authors:  M C Arenas; C I Navarro-Francés; S Montagud-Romero; J Miñarro; C Manzanedo
Journal:  Psychopharmacology (Berl)       Date:  2018-06-29       Impact factor: 4.530

3.  Updating neuropathology and neuropharmacology of monoaminergic systems.

Authors:  Rona R Ramsay; Philippe De Deurwaerdère; Giuseppe Di Giovanni
Journal:  Br J Pharmacol       Date:  2016-07       Impact factor: 8.739

4.  Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats.

Authors:  Laura J Mosher; Roberto Frau; Alessandra Pardu; Romina Pes; Paola Devoto; Marco Bortolato
Journal:  Br J Pharmacol       Date:  2015-07-30       Impact factor: 8.739

5.  The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.

Authors:  Roberto Frau; Laura J Mosher; Valentina Bini; Giuliano Pillolla; Romina Pes; Pierluigi Saba; Silvia Fanni; Paola Devoto; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2015-09-24       Impact factor: 4.905

6.  Nicotine ameliorates schizophrenia-like cognitive deficits induced by maternal LPS exposure: a study in rats.

Authors:  Uta Waterhouse; Vic E Roper; Katharine A Brennan; Bart A Ellenbroek
Journal:  Dis Model Mech       Date:  2016-05-11       Impact factor: 5.758

7.  Maternal Immune Activation Sensitizes Male Offspring Rats to Lipopolysaccharide-Induced Microglial Deficits Involving the Dysfunction of CD200-CD200R and CX3CL1-CX3CR1 Systems.

Authors:  Katarzyna Chamera; Magdalena Szuster-Głuszczak; Ewa Trojan; Agnieszka Basta-Kaim
Journal:  Cells       Date:  2020-07-12       Impact factor: 6.600

8.  The prenatal challenge with lipopolysaccharide and polyinosinic:polycytidylic acid disrupts CX3CL1-CX3CR1 and CD200-CD200R signalling in the brains of male rat offspring: a link to schizophrenia-like behaviours.

Authors:  Katarzyna Chamera; Katarzyna Kotarska; Magdalena Szuster-Głuszczak; Ewa Trojan; Alicja Skórkowska; Bartosz Pomierny; Weronika Krzyżanowska; Natalia Bryniarska; Agnieszka Basta-Kaim
Journal:  J Neuroinflammation       Date:  2020-08-23       Impact factor: 8.322

9.  Tspyl2 Loss-of-Function Causes Neurodevelopmental Brain and Behavior Abnormalities in Mice.

Authors:  Qi Li; Siu Yuen Chan; Kwun K Wong; Ran Wei; Yu On Leung; Abby Y Ding; Tomy C K Hui; Charlton Cheung; Siew E Chua; Pak C Sham; Ed X Wu; Grainne M McAlonan
Journal:  Behav Genet       Date:  2016-01-29       Impact factor: 2.805

Review 10.  Addressing the Complexity of Tourette's Syndrome through the Use of Animal Models.

Authors:  Ester Nespoli; Francesca Rizzo; Tobias M Boeckers; Bastian Hengerer; Andrea G Ludolph
Journal:  Front Neurosci       Date:  2016-04-08       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.